Gut Microbiome Composition in Dystonia Patients.

Area of Science:

• Neuroscience
• Microbiology
• Genetics

Background:

• Dystonia is a movement disorder characterized by involuntary movements and postures.
• Non-motor symptoms, including psychiatric issues, sleep disturbances, and fatigue, are prevalent in dystonia patients.
• The gut-brain axis is a potential pathway influencing neurological disorders.

Purpose of the Study:

• To investigate the gut microbiome composition in dystonia patients compared to healthy controls.
• To explore the abundance of neuro-active metabolic pathways potentially linked to dystonia symptoms.
• To examine the relationship between the gut microbiome and (non-)motor symptoms in dystonia.

Main Methods:

• Metagenomic and 16S rRNA sequencing of stool samples from dystonia subtypes (cervical dystonia, dopa-responsive dystonia, myoclonus-dystonia) and controls.
• Analysis of gut microbiome diversity (alpha and beta).
• Quantification of neuro-active metabolic pathways, including tryptophan degradation.

Main Results:

• No significant differences in overall microbiome alpha and beta diversity between dystonia patients and controls.
• Dystonia patients exhibited higher abundances of *Ruminococcus torques* and *Dorea formicigenerans*, and lower abundance of *Butyrivibrio crossotus* compared to controls.
• Reduced abundance of neuro-active pathways, particularly tryptophan degradation, was observed in dystonia patients.
• Non-motor symptoms and plasma neurotransmitter levels explained gut microbiome variance in dystonia.

Conclusions:

• The gut microbiome composition differs between dystonia patients and controls.
• Alterations in specific gut bacteria and neuro-active pathways suggest a role for the gut-brain axis in dystonia pathophysiology.
• Further research is warranted to confirm these preliminary findings and elucidate the mechanisms involved.